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Toxicity, Uptake, and Mutagenicity of
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Glenn G. Fletcher,1 Franco E. Rossetto,1 John D. Turnbull,2
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Toxicity testing in AS52 cells (24-hr exposures) gave LC50 values of 2 to 130 pg Ni/ml for particulate nickel compounds and 45 to 60 pg Ni/ml for
water-soluble salts (NiCI2, NiSO4, Ni(CH3COO)2). The Ni(OH)2, NiCO3, and sulfides (Ni3S2, Ni7S6, "amorphous NiS") exhibited similar toxicities
(LC50's of 2 to 8 pg Ni/ml), while three nickel oxides were more variable and less toxic (LC50's of 18 to 130 pg Ni/ml). Most compounds displayed
nuclear to cytoplasmic nickel ratios of - 1:1.5 to 1:5 (except - 1:20 for nickel salts). At the LC50's, a 75-fold range in exposure levels occurred com-
pared to a 10-fold range in cytoplasmic and nuclear nickel concentrations, [Nil. Cellular nickel distribution indicated three groupings: inert compounds
(green NiO, lithium nickel oxide, relatively low nuclear and cytosolic [Nil); water-soluble salts (very low nuclear [Nil; high cytosolic [Nil), and slightly
soluble compounds (relatively high cytosolic and nuclear [Nil). Nickel compounds are considered to be only weak or equivocal mutagens. In this
study, a low but significant increase in mutation rate at the gpt locus was shown. Although the results would not be sufficient to deem nickel com-
pounds mutagenic by traditional criteria, characterization by PCR analysis indicated that the spontaneous and nickel-induced mutants exhibited differ-
ent and compound-specific mutational spectra (thus confirming nickel compound involvement). The results reported illustrate some of the
methodologic problems involved in testing "weak" mutagens and indicate that alternative approaches may be necessary in classifying the muta-
genicity of nickel and other compounds. - Environ Health Perspect 102(Suppl 3):69-79 (1994).
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Introduction
Single injections of experimental animals
with crystalline nickel compounds such as
Ni3S2 and NiS have been found to result in
a 90 to 100% incidence of tumors at the
exposure site (1-3). By contrast, water sol-
uble compounds (NiCl2, NiSO4) do not
induce tumors, while amorphous NiS does
so weakly. More recently, however, the
repeated administration of nickel salts has
produced a low incidence of malignancies
in rats (4). In cell culture both crystalline
and soluble compounds induce transforma-
tion, though soluble compounds must be
present at much higher levels (2,5-7).
Amorphous NiS has not exhibited trans-
forming activity. Cellular transformation
and toxicity have been found to depend on
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the ability of nickel to enter the cell by
phagocytosis (8-10). Attempts to explain
the mechanism of action and potency dif-
ferences between various nickel compounds
have lead to the "Nickel-Ion Hypothesis"
(11,12). This hypothesis suggests that the
nickel(II) ion is the active agent in nickel
toxicity, mutagenesis and carcinogenesis,
and that its intracellular concentration is a
major determinant, irrespective of the
nickel compound to which an organism
is exposed.
Despite their tumorigenicity in man
and animals, nickel compounds and many
other metal compounds have not been
found to be mutagenic in traditional in
vitro test systems. In the established
CHO/hprt mutation assay large deletions
and rearrangements extending past the hprt
locus may affect or delete neighboring
genes necessary for survival, thus decreasing
the ability to detect or quantify certain
types of mutagens (13). An approach to
circumvent this problem was to use AS52
cells, which are CHO cells modified by
deleting most of the hprt gene and adding
the corresponding bacterial xprtgene (gpt)
to a somatic chromosome (14,15). Thus,
in addition to base substitutions, frame
shifts, small deletions, additions, and chro-
mosome breakage and rearrangements nor-
mally measured in CHO cells (16), the
new location ofthis gene is known to allow
detection ofmutations caused byX-irradia-
tion (which causes large deletions). With
this modification we hoped to be able to
detect nickel-induced mutations, which are
suspected to involve large DNA deletions
or rearrangements.
Materials and Methods
Preparation andCharacterizationof
Nkkd Compounds
Nickel hydroxide was synthesized by slowly
mixing 0.6 M NiSO4.7H20 and hot 1.4
M NaOH followed by centrifugation and
filtration to collect the precipitate [modi-
fied from Kasprzak et al. (17)]. Heating at
80°C for 20 hr to dry and improve crys-
tallinity gave a dark-green product. The
sample was ground in a Spex 8000
Mixer/Mill (Spex Industries, Metucher,
NJ) with tungsten carbide grinding vial
and the light green powder was dry-sieved
through a series ofwire mesh sieves (#100,
#200, #325, #400; respectively, 150, 75,
45, 38 pm openings). Particles not passing
through the last sieve were reground and
sieved, then wet sieved by suspending in
water and filtering through 25 pm and
5 pim sieves. Particles passing through the
final 5 pm sieve were collected by centrifu-
gation. The Ni(OH)2 was dried at room
temperature and then at 80°C for 5 hr.
NiCO3, which was to be essentially
free ofnickel hydroxide, was prepared by a
procedure suggested by V. J. Zatka (per-
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Table 1. Identification of compounds.
Sample Name and formula in text Formula from chemical analysisa Species fromX-raydiffraction analysis
1 Nickel hydroxide, Ni(OH)2 Ni(OH)2.0.04 NiCO3.0.6 H20 Ni(OH)2
2A Nickel carbonate, NiCO3 NiCO3.0.55 Ni(OH)2.3.7 H20
2D Nickel carbonate, NiCO3 NiCO3.0.58 Ni(OH)2.4.2 H20 NiCO3.6H20
3 Black nickel oxide, NiO NiO NiO
4 Green nickel oxide, NiO NiO NiO
5 Lithium nickel oxide Li223Ni8010.22 Li2Ni8010 or NiO
6 Amorphous nickel sulfide, NiS NiS2.2.25 NiSO4.6H20.4.76 NiS NiS2 + NiSO4.6H20
7 a-Ni7S6 a-Ni7S6+ 5% NiS + 1% NiSO4 a-Ni7S6 (major); NiS + NiSO4+Ni3S2 (minor)
8 Nickel subsulphide, Ni3S2 Ni3S2 Ni3S2
9 Nickel chloride, NiCI2 NiCI2.6 H20
10 Nickel sulfate, NiSO4 NiSO4.7 H20
11 Nickel acetate, Ni(CH3COO)2 Ni(CH3COO)2.4 H20
aNickel salts(nos. 9-11)were identified byproduct labelsand suppliers' documentation.
sonal communication). (NH4)2CO3 and
Ni(NO3).26H20 solutions were cooled to
0°C. The Ni(NO3)2 solution was slowly
added to the C02-saturated (NH4)2CO3
solution, then the mixture let stand for 6
days at room temperature to allow forma-
tion of blue-green NiCO3 crystals. The
solution plus cold water used to rinse the
crystals were poured through a 5-pm sieve.
The combined filtrates were centrifuged to
collect the < 5 pm fraction ofNiCO3 par-
ticles. These particles were left to dry at
room temperature, then collected for in
vitro testing. This light green product is
referred to as NiCO3 sample 2A (<10 pm
without grinding). Larger particles (>25
Incubation ofcels with nickel compound (5 or 24 h)
Renoval of incubaton medium
Rinsing ofcells (medium; phosphaie buffered saline, PBS)
Trypsinization to release cela fron plates
Isolation of cells by centrifugation
Rinsing of cell pellet (PBS)
Resuspension in hypotonic buffer
Lysing ofcells witi non-ionic detergent
Pelleting of intact nuclei and pauticulates by
centrifugation
Removal ofsupernatant (cell cytosol) for analysis
Rinsing of nuclear pellet
Resuspension in buffer + DNAase I
Incubation at 37°C for 15 min
Addition of SDS and Poteinase K
Incubation at 60°C for 45 min
Removal ofparticulates by centifugation
Analysis of nuclear supematant
Figure 1. Nuclear isolation flowchart.
pim) air dried and ground were kept
for characterization but not used in the in
vivo tests.
Amorphous NiS was prepared using a
15% NiCl2 solution and excess 22%
(NH4)2S (10) in an acetate buffered sys-
tem. The pH was measured periodically
and glacial acetic acid added as required to
keep the pH in the range of4.0 to 6.0. The
product was filtered and rinsed with water
and acetone, dried at 110°C for 17 hr, then
ground in the Spex grinder. Particles sieved
and collected as described for the nickel
hydroxide were sterilized in acetone and
dried for 5 hr at 80°C.
Black NiO, Li2Ni8010 (nickel oxide in
which 2.39% Li stabilizes a Ni(III) content
of 19.2%), crystalline a-Ni7S6, and crys-
talline nickel subsulphide (Ni3S2) were
obtained from INCO Limited (Toronto,
ON) and green NiO was purchased from
Johnson Matthey Chemicals (Brampton,
ON) (puratronic grade). These compounds
were wet-sieved through a 25-pm sieve and
10-pm nylon Spectra/mesh disposable fil-
ter. Particles were collected by centrifuga-
tion, sterilized in acetone, centrifuged, and
then dried for 5 hr at 800C.
High purity nickel chloride and nickel
sulfate were purchased from BDH
(Toronto, ON) (analar grade) and nickel
acetate from Johnson Matthey (puratronic
grade). Stock solutions were made in water,
filter-sterilized through 0.22-pm filters, and
stored in sterile glass bottles. NiCl2 and
NiSO4 were prepared as 500 mM stock
solutions, while Ni(CH3COO)2 was made
as a 100 mM stock solution.
The nickel, sulfur, and minor con-
stituent contents of the compounds pro-
vided by INCO Ltd. (Toronto, ON) were
determined by them. The amorphous NiS,
Ni(OH)2, and NiCO3 samples were ana-
lyzed chemically at INCO's Sudbury or
Mississauga facilities. Formulas of the
nickel salts (water soluble compounds)
were assumed to be accurate as reported on
the labels and in the suppliers' catalogues.
X-ray crystal powder diffraction pat-
terns were obtained for all of the particu-
late compounds. Diffraction analysis was
performed at the Institute for Materials
Research, McMaster University, using
Cu-Ka radiation at 1.5405A. Samples were
then identified (Table 1) by comparing lat-
tice spacings and peak intensities to stan-
dard spectra available in the JCPDS data
base (18).
CG Culture
AS52 cells derived by modification of the
CHO-KI line were kindly provided by
K. R. Tindall, National Institute of
Environmental Health Sciences (Research
Triangle Park, NC). These cells were
grown in Ham's F12 medium (F12) with 5
to 10% fetal bovine serum (FBS). Dialyzed
FBS was used in mutation testing proce-
dures. Prior to mutagenicity studies, the
medium was supplemented with 10 pg/ml
mycophenolic acid, 25 pg/ml adenine, 50
pM thymidine, 250 pg/ml xanthine, and 3
pM aminopterin (MPA medium), to elimi-
nate spontaneous mutants. Antibiotics
were not added for routine culturing,
though 100 U penicillin G, 100 pg strepto-
mycin, and 0.25 pg amphotericin B per ml
medium were employed in individual
experiments. Cells were grown in a 37°C,
95 to 100% humidity, 5% CO2 (continu-
ous flow) incubator, and routinely subcul-
tured every 3 to 4 days. A doubling time of
14 to 18 hr and plating efficiencies of50 to
70% were observed. A Coulter Model ZF
particle counter was used for cell-number
determinations.
Environmental Health Perspectives 70TOXICITY, UPTAKE, ANDMUTAGENICITY OFNICKEL COMPOUNDS
Taoxity of N(O2 inAS52 Colb
U SurvislvnDos
Toxkity of NIC03 hAS52 Colb
U Survlvelve Dos
Toxicity of Bhkk N1O InAS52 CSlb
%Survmlvs Dess
- v EH E, -^I
IF fXffl v w
7 a a
N1C03BAPogN*4
Toxicity ofCGon NIO hAS52 Colb
#Strvvalvs DOo
0 IN 2C
GranMO d
2SD 30
bd,pgN*nL
Toxicityof Llthlun NkieOxd InAS52 Celb
U Suwrvlw Doss
XNtuIl
0K Aigap
£ Avg std
. Avg-std
D
Toxkityof M756 InAS52 Colb
XSurvivai D Oss
I a A a 3
MO7S addsd,po l,
Nmi SrVINX
VU Amrgs
A Avg+std
Avg-td
G
a I I I
m I I
I I Tl IV L
: T 1 1 7 1 1 1 1~~~~~IV~ . --I| | | I % ^ .1 1^ k
I 2dl5DI =
Odd d WN i L12NII01 ad,pg NFL
XSrylu
N A^iss
Avg+Std
v AVg- td
E
Toxicityof N13S2 InASS2 Coeb
XSrvushiVs Oss
XSvulv
W A^ra
A AVG..td
Avg-std
I,
H
Toxicity of tArphow NIS hIA552 Cob
XSuvlne Dom
4 5NISc A"PuOAphMSadded. II ON5L
Toxiciyof NIC12 InASS2 Cob
X Survnsvs Dm(5 houtaoss)
210mO 2YD 300 31
Nl2ddsdpa Nrd.L
Toxicityof NIS04nAS52 Colb
X Srvlvslvs Om (5houur)porn)
XSulrvi
1 Amig
A AVg std
Avg-ltd
J
Toxkity of NidcelAcetate InAS52 Colb
X Stvlvulvs Done(5horuposs)
TIf510 90 1 10 t 1& ^
Idft pg qPO& l [ 1- arvid
I r 1l || 1 K^
I,
Toxkityof NkcIdo Sifts InAS52Cob
XSurvtilswv DOo(24 howrspu as)
40 U U o
Ndrlgot adsdPoRd
Figure 2. Nickel toxicity curves in AS52 cells. AS52 cells were seeded in F12/10% FBS medium at 500cells per60mm diameterdish 2 days beforetreatment.The cells were exposed
to the range of nickel compounds in serum-free medium atthe concentrations indicated for 24 hr(or 5 hr exposure for nickel salts, as noted). The cells were rinsed to remove extracel-
lularnickel, then incubated in fresh F12/10% FBS medium until colonies formed to 9 days). The percentsurvival was determined bycomparing the numberofcolonies counted tothe
numberobtained in control (nonexposed) dishes. Averages are based on three to five replicateexperiments(three dishes perexperiment pertestcondition)foreach compound. (Tofacil-
itate semilogarithmic plotting of the data, survival values and standard deviations (std) less than 1 have been either omitted or plotted as 1% survival,
as appropriate.)
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ToxidtyTeting
AS52 cells from a near confluent culture
dish were released with trypsin, counted,
diluted, and replated at 500 cells per 60
mm diameter dish in F12 medium with
10% fetal bovine serum (F12/10). One to
two days later, the medium was replaced
with serum-free medium (F12/0) and the
test compound was added. After an expo-
sure period of 24 hr, or 5 hr for nickel
salts, the medium was removed and the
cells rinsed to remove nickel not taken up
by the cells. The F12/10 medium was
renewed and then the cells were incubated
for 6 to 8 days until colonies of sufficient
size to be counted developed. Colonies
were stained using a solution of0.5% crys-
tal violet in ethanol, thereby producing
clearly visible, circular colonies of a deep
violet color. These colonies were then
counted using an automated colony
counter and the number per dish relative to
the number in untreated control culture
dishes (relative % survival) was reported.
Analysis ofNickel Contentin Cells,
Nudei, andCytsol
To get a measure of the biologically
available nickel levels (as opposed to total
nickel present), we set out to determine the
dissolved nickel (nickel ion) levels in the
cytosol and nuclei. The final procedure
used to assess the cytosolic fraction and a
nuclear fraction free of particulates is out-
lined in Figure 1. To assess possible contri-
butions to the measured nickel levels from
particulate dissolution during the cellular
fractionation protocol outlined in Figure 1,
simulation experiments were conducted for
green NiO and Ni3S2. All samples were
analyzed by electrothermal atomic absorp-
tion spectrometry (EAAS). A Perkin Elmer
Atomic Absorption Spectrometer Model
703 (Rexdale, ON) furnished with
a graphite furnace Model HGA-500
was used.
MutagenicityTesting
Cells growing in MPA medium were
replated in F12/10% FBS on day -2.
On day 0 the medium was replaced with
serum-free F12 and the nickel compound
or ethylmethanesulfonate (EMS, positive
control) was added. Test doses for particu-
late nickel compounds were chosen to give
20 to 80% survival based on previously
determined toxicity curves. After an expo-
sure period of24 hr for particulates or 5-hr
for nickel salts and EMS, the medium was
removed and the cells rinsed with F12/5%
FBS to remove nickel not taken up by the
cells. For 5-hr exposures, fresh F12/10%
Table 2. Nickel compound LC50 values in AS52 and CHO cells and corresponding cytosolic and nuclear nickel
levels.
LCia LC50 Nickel Dissolution
compound, nickel, pg/i06cells, halftime(T5o)C
Compound pg/mI ormM pg Ni/ml cytosolb.f Nucleib,g (rator human serum
1 Ni(OH) 3.6 pg/ml 2.0 0.16 0.08 < 1 day
2 NiCO3 14.9 5.8 0.80 0.07
3 Black NiO 23.3 18.1 0.11 0.045 0.8year
4 Green NiO 165.4 130.0 0.035 0.007 >11 years
5 Li2Ni6801 103.6 75.0 0.06 0.018
6 Amorphous NiS 10.0 4.1 0.25 0.07 24daysd,<96dayse
7 Ni7S6 12.1 8.2 0.08 0.055
8 Ni3S2 5.6 4.1 0.19 0.08 28 days
9 NiCI2(5 hr) 2.6 mM 150 0.22 0.006
10 NiSO4(5 hr) 2.1 125 0.17 0.007
11 Ni(CH3COO)2(5 hr) 2.0 120 0.16 0.008
12 NiCI2(24hr) 1.0 60 0.18
13 NiSO4(24 hr) 1.0 60 0.17
14 Ni(CH3COO)2(24 hr) 0.8 45 0.15
[LC50 is the concentration at which the survival of exposed cells is 50% of that of nonexposed control cells as deter-
mined in colonyforming assays. Values were determined from Figures 2Ato 2L. bDissolved cytosolic and nuclear nickel
levels determined from plots ofthe data inAppendix 1. cFrom reference Kasprzaketal. (17); Kuehn etal. (20); Thomhill
et al. (21). dValue for amorphous NiS. eValue for NiS2 determined in water. fFor plot of LC50 vs cytosolic nickel,
LC50 = 75-87 Nic,osol, r = -0.29, p > 0.05, n = 14. gFor plot of LC50 vs nuclear nickel, LC50= 129-1810 Ninuciei,
r = -0.93, p < 0.01, n = 11.
Table 3. Nickel compound mutagenicity in AS52 cells.a
Amount of Mutation Confidence Dose-response
nickel frequency/ interval, correlation
Compound pg Ni/mlb 106 cells 95% levelc coefficient, rc
Ni(OH2 1.1 25 10 - 40 0.974e
, ~~~~~. X1
NiCO3
NiO, black
NiO, green
Li2Ni801o
NiS, amorphous
Ni7S6
1.7
2.4
3.4
5.5
2.5
4.4
6.2
8.2
11.2
9.5
14.0
18.1
22.2
31.8
85
144
180
282
38
60
76
101
146
1.8
2.8
3.9
5.2
7.1
3.2
5.7
8.6
48U
43d
75d
84d
33
18
23
58d
44d
51d
30
42d
28
79d
38d
40d
38
42d
30
35
20
33
20
43d
33
64d
83d
53d
18
39d
39 - 58
27 - 58
55 - 95
66 -103
24 - 43
7- 30
10 - 35
38 - 79
26 - 62
41 - 61
8- 52
32 - 51
17 - 38
61 - 98
26 - 51
20 - 60
24 - 51
20 - 64
21 - 39
29 - 41
11 - 29
17 - 48
44 - 56
11 - 29
30 - 57
28 - 37
43 - 86
53 -114
37 - 69
5- 30
22 - 56
0.626
0.695
0.826
0.822
0.953 e
0.623
continuedonnextpage
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Table 3 (continued). Nickel compound mutagenicity in AS52 cells.a
Amount of Mutation Confidence Dose-response
nickel frequency/ interval, correlation
Compound pg Ni/mlb 106 cells 95% levelc coefficient, rc
Ni7S6
Ni3S2
NiCI2
5 hours
NiSO4
5 hours
Ni(CH3COO)2
5hr
NiCI2
24hr
NiSO4
24 hr
Ni(CH3COO)2
24hr
Positive
controls
(EMS)
10.5
19.3
1.6
3.0
4.3
6.2
9.1
59
117
176
235
294
59
117
176
235
294
59
117
176
235
294
14.7
29.4
44.0
58.7
73.4
14.7
29.4
44.0
58.7
73.4
14.7
29.4
44.0
58.7
73.4
50 pg/ml
100 pg/ml
200 pg/mI
300 pg/ml
400 pg/mI
Negative
controls
(noaddition)
32
63d
33
38
44d
62d
49d
25
58d
60d
8
47d
49d
56d
68d
59d
67d
12
33
57d
20
57d
72d
18
30
15
55d
51d
45d
44d
46d
24
32
23
53d
37
121d
208d
273d
444d
352d
33
28
37
31
16
4 - 59
54- 73
19- 47
22- 53
26- 62
47- 76
35- 63
19- 31
39- 76
45- 75
3- 14
33- 61
41 - 58
39- 73
46- 89
45- 74
52- 81
4- 20
15- 50
44- 70
10- 30
49- 65
56- 87
10- 27
15- 45
10- 20
49- 61
36- 66
32 - 58
20- 68
20- 72
15- 34
20- 43
15- 30
37- 68
26- 47
102 -139
195 -220
253 -292
428 -460
321 -383
19 - 48
12- 43
26- 47
21 - 40
11 - 21
0.932e
0.130
0.570
0.632
0.246
0.886e
0.637
0.969e
Average 29 24 - 34
BAS52 cells grown in MPA medium to eliminate spontaneous mutations or loss ofthe gptgene were plated in F12/10%
FBS 2 days( 5.105 cells/100 mm dish) priorto treatment. Cells were exposed to the test compounds for 24 hr(or 5 hr
for nickel salts, as indicated) in serum-free medium, then rinsed, trypsinized, and replated in F12/10% FBS. The cells
were subcultured every3 days as required during theexpression period of8days. Afterthisperiod, 6-thioguanine resis-
tant mutantswere selected byplating at2x105cells/100 mm dish in 10 ml F12/10% dialyzed FBS plus 10pM6-thiogua-
nine. Atthis same time 500 cells/60 mm dish were plated in medium withoutthioguanine for determination of plating
efficiency. After 10to 15days,disheswere rinsedwith PBSandcolonies stained andcounted. Themutationfrequency is
expressed asthenumberofmutantcolonies permillion cellsplated. Results arereported inthistablefor asingle experi-
ment based on 5 to 6 dishes per treatment condition with further replicates for negative controls as indicated. tTest
doses were selected to correspond to formal survival rates of 80%, 65%, 50%, 35%, and 20%. See Table Al for
amounts ofthecompound added. cTwo-tailed significance test.dSignificantlydifferentfrom control rates byone-tailed t-
test, atthe0.05probability level orbetter. 'Significant atthe0.05probability level orbetter.
FBS was added, the cells were incubated 19
to 24 hr, and were then rinsed once with
phosphate-buffered saline (PBS). For 24-hr
exposures, the cells were rinsed with PBS.
Subcultures were made on day 1 and every
2 to 3 days thereafter to allow expression of
the altered gene, with a larger number of
cells replated from cultures in which a
lower survival was expected, so that at the
next replating approximately equal densi-
ties were reached. On day 9 the cells were
replated at 2 x105 cells/100 mm dish (5 or
6 dishes per treatment condition) in 10 ml
F12/10% dFBS (or 5% dFBS and 5% dia-
lyzed calf serum) plus 10 pM 6-thiogua-
nine (6-TG) to select for gpt mutants. At
the same time, 500 cells/60 mm dish (3
dishes per treatment condition) were plated
in the same medium without 6-TG for a
plating-efficiency (PE) determination.
After 8 days (day 17), the PE dishes were
rinsed with PBS and stained with crystal
violet. Following a selection period of 10 to
12 days the 6-TG-resistant colonies (loss of
xanthine-guanine phosphoribosyl trans-
ferase (XPRT) activity at the gpt locus)
were stained with crystal violet
and counted.
CharacterizationofMutants
Colonies were picked off plates and
clonally expanded to approximately 106
cells. Approximately 0.5 to 1 pg ofmutant
DNA was amplified by the polymerase
chain reaction (PCR) employing suitable
primers encompassing the gpt gene. These
primers constituted the starting points for
the DNA synthesis (polymerization). The
products were separated by electrophoresis
on a 1% agarose gel, which was subse-
quently stained with ethidium bromide.
Additional details are provided in Rossetto
etal. (19).
Results
ChaterizationofNickel
Compounds
Results of the chemical and X-ray diffrac-
tion analysis of the nickel compounds are
given in Table 1. The percent nickel was
used to convert from pg compound/ml (as
weighed out) to pg nickel/ml, the units
reported in the tables and figures.
For Sample 1 (nickel hydroxide), the
X-ray diffraction peaks were too broad to
allow an accurate measurement ofd values
or the diffraction angles (20), though the
pattern was qualitatively consistent with
the Ni(OH)2 standard. Chemical analysis
was compatible with Ni(OH)2.0.6H20,
with possibly a very small amount of
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NiCO3A(0.04 per Ni(OH)2 unit). Sample
2A showed no observable diffraction
planes, though Sample 2D (larger particles)
corresponded to the NiCO3.6H20 stan-
dard. The chemical analyses for Samples
2A and 2D were similar, indicating the
same chemical make-up, although differ-
ences in the degree of crystallinity existed.
Though none is indicated in the X-ray pat-
tern, chemical analysis suggested a signifi-
cant amount of nickel hydroxide might
have been contained in the carbonate sam-
ples. The hydroxide, if present, was
expected to be in a noncrystalline (amor-
phous) form. The black and green nickel
oxides were indistinguishable by their
diffraction patterns and corresponded to
the NiO standard. Sample 5 exhibited
characteristics of both the NiO and
Li2Ni8O10 diffraction patterns. Chemical
analysis, however, indicated a formula of
Li2.23Ni8010.22* Sample 6, expected to be
-in- u a,vwI
-.*uaws Ro*n
-41-[NIJincytuol
Figure 3. Toxicity, mutagenicity, and uptake of Ni3S2 in
AS52 cells after 24 hr exposure. The data plotted in this
summary figure were derived from those depicted in fig-
ure2H orcompiled inTables3andAl.
Al- X5sajyl
Figure 4. Toxicity, mutagenicity, and uptake of NiSO4 in
AS52 cells after 5 hr exposure. The data plotted in this
summary figure were derived from those depicted in
Figure2J orcompiled inTables3andAl.
amorphous NiS, according to the diffrac-
tion pattern contained a mixture of NiS2
and NiSO4.6H20. These are possible oxi-
dation products in the formation of NiS,
though they do not account for the ana-
lyzed nickel and sulfur contents. The high
background in the diffraction pattern
obtained suggested that a noncrystalline
component was present, the most likely
species being amorphous NiS (, 60 mole
percent). For Sample 7, the complexity of
the pattern prevented a definite identifica-
tion, although a-Ni7S6 appeared to be the
major component. Other nickel/sulfur
compounds were probable, with NiS,
anhydrous NiSO4, and Ni3S2 implicated.
Sample 8 was definitively identified
as Ni3S2 by both X-ray diffraction and
chemical analysis.
ToxicityofNiwkel Compounds
Dose-response curves showing the percent
survival of the exposed cells (with respect
to untreated control cells) versus the
amount of nickel added to the culture
medium are given in Figure 2 (2A to 2L)
for the 11 compounds tested. The average
percent survival and standard deviation
depicted were calculated from the results of
at least 3 replicate experiments. LC50 values
(concentration which kills 50% of the
exposed cells) were obtained from the
respective graph for each compound tested
and are given in Table 2 alongwith cellular
nickel levels. To facilitate comparison of
the various compounds, concentrations are
expressed in units ofpigNi/ml.
NicklUptake
Appendix Table Al summarizes the non-
particulate ("dissolved") nickel contents of
the cell cytosol (average of 4 experiments)
and ofthe cell nuclei (average of 2 experi-
ments). Exposure doses are the same as
those used in the mutation experiments.
For most of the compounds, a significant
(p<0.05) relationship exists between
administered dose and observed intracellu-
lar nickel concentrations.
MutgenicityTesting
Representative mutation frequencies for 6-
thioguanine (6-TG) resistance induced by
the various nickel compounds are summa-
rized in Table 3. The mutation frequency
represents the number of mutations
observed per million cells plated. At the
time of selection, the cells had recovered
such that the PE of treated cultures were
approximately the same (40 to 50%) as the
negative (nonexposed) controls, regardless
of the exposure dose of the nickel com-
pound. The plating efficiencies of the
EMS-treated cells (17 to 34% depending
on dose) were significantly lower than
the controls.
The mutation frequency of non-
exposed cells observed in separate experi-
ments appears to adhere to a normal
statistical distribution. In 4 mutation
experiments, 12 independent assessments
(69 dishes total) yielded a spontaneous
mutation rate of 26 ± 2.5 (mean ± sd;
range 0-55). The statistical significance of
the increase in mutation frequency after
nickel exposure was assessed by comparison
to the negative control data (no nickel
added). Since the mutation frequency
reported for the test compounds is based
on the average of 5 to 6 replicate dishes in
the same experiment, the standard devia-
tion and the 95% confidence interval for
each exposure condition were calculated;
and are denoted as upper and lower limits
in Table 3. A comparison of the mean
mutation frequency with that of non-
exposed (negative) control cultures using
the one-tailed Student's t-test was
employed to determine the significance of
the nickel-induced mutation rates. For
each compound, the results were also tested
for the significance of the correlation
between the administered nickel dose and
the induced mutation rate. For this com-
parison, the correlation coefficient (r) was
calculated and the significance determined
using standard two-tailed statistical tables.
In Figures 3 and 4, the mutagenicity
and nickel uptake data are plotted in con-
junction with the cytoxicity results for
Ni3S2 and NiSO4. As is evident from the
data in Table 3, the increase in mutation
frequency with intracellular nickel uptake
is significant (p<0.05) only for Ni(OH)2,
"amorphous NiS", Ni3S2, and NiSO4.
MutantCh izton
Sequencing and restriction analysis of the
two PCR products observed revealed that
the smaller (lower relative molecular mass)
band corresponds to the functional gpt
locus, while the larger band is functionally
inactive [designated as a pseudogene,
(19)]. Northern blot analysis of mRNA
and reverse transcriptase PCR (RT-PCR)
analysis of both mRNA and total RNA
confirms this (data not shown). Analysis of
the amplification products on an agarose
gel (1%) revealed 3 distinct alterations at
the gpdpseudogene loci: both PCR DNA
bands remain intact; the smaller DNA
band (corresponding to the functional gpt
gene) is absent; or both bands are absent.
Repetition ofthe PCRwork has confirmed
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the qualitative characterization of the
observed mutants reported in Figure 5.
In addition, re-evaluation of the mutants
with a second primer set encompassing the
gptgene and larger stretches ofDNA both
upstream and downstream of the gene
has also corroborated the depicted muta-
tion profiles. Details are given in Rossetto
et al. (19).
Discussion and Conclusions
MajorFinding
X-ray diffraction characterization of"amor-
phous NiS" synthesized from NiCl2 and
(NH4)2S in the presence of air illustrates
the difficulty of preparing a pure product
without impurities such as NiS2 and
NiSO4, at least under the conditions
employed. The synthesis procedure used
differed from that ofAbbracchio et al. (10)
only in our use of an acetate buffered
medium. Both the cytotoxicity (LD50 = 4.1
pg Ni/ml) and mutagenicity of "amor-
phous NiS" suggest that crystalline NiS2 is
a sulfide of high cytotoxic and genotoxic
potency. Carcinogenicity studies ofNiS2 in
rats support this conclusion (3). In view of
the X-ray diffraction evidence for the pres-
ence ofNiS2, the alternate explanation that
the unexpected activity of amorphous
nickel sulfide was due to negative surface
charges, which is known to make it biolog-
ically active (22), is less likely.
Contributions to the measured nickel
levels from particulate dissolution during
the cellular fractionation process is judged
to be small. Simulation experiments incor-
porating the protocol oudined in Figure 1
(i.e., same buffers, incubation periods, and
temperatures) indicated that little of the
particulates dissolved (0.01% for green
NiO and 0.9% for Ni3S2), in agreement
with the known serum dissolution half-
times (T50) of >11 years and 28 days,
respectively (Table 2). In contrast to the
other particulate nickel compounds stud-
ied, there was no visible evidence of resid-
ual particulate material during the
manipulations summarized in Figure 1
for Ni(OH)2 (T50<1 day, Table 2)
and NiCO3, both ofwhich are reported to
be slightly soluble in water, rather than
insoluble (23).
As illustrated by the toxicity curves of
Figure 2A to 2L and the LC50 data in
Table 2, there are significant differences in
the toxicity of the various nickel com-
pounds tested. For particulate compounds,
the range of LC50 values is from 2 pg
Ni/ml for Ni(OH)2 to 130 pg Ni/ml for
the green NiO. For the water-soluble salts,
the LC50 increased from 45 to 60 pg Ni/ml
for 24-hr exposures to 120 to 125 pg
Ni/ml for 5-hr exposure. The (Ni(OH)2,
carbonate, and sulfides show similar toxici-
ties, while the nickel oxides are shown to
be less toxic, with the potency depending
on the compound tested (green, black, or
containing Ni(III)/Li). The cytosolic and
nuclear nickel contents of the compounds
at a given cytotoxicity level show consider-
ably less variation than the administered
dose. Thus at LC50, the cytosolic nickel
levels observed were in the range of 35 to
250 ng/106 cells (NiCO3 exempted), while
levels of6 to 80 ng/106 cells were observed
in the nuclear fraction (Tables 2,A1). The
particulate compounds with the lowest tox-
icity (green NiO and NiO with Ni(III)/Li),
and therefore necessitating the highest
extracellular nickel concentrations to give
measurable cell toxicity, show the lowest
intracellular nickel levels. Because consider-
able cytotoxicity occurred for these 2 com-
pounds, an influence other than dissolved
nickel in cells appears to contribute to the
loss ofcellviability.
The compounds exhibiting the strong-
est mutagenic responses-Ni(OH)2
"amorphous NiS," and Ni3S2, have the
highest nuclear nickel levels and the lowest
administered doses. Although nickel com-
pounds appear to be only weak mutagens,
the present results do indicate a significant
increase (p<0.05) in mutation rate for the
nickel compounds, although not consis-
tently at all doses tested. The Ni(OH)2,
Ni3S2, and "amorphous NiS," which not
only exhibited evidence for a significant
dose-response (p<0.01 or p<0.05) but also
increased mutation frequencies relative to
control cultures (p<0.025), might be
termed mutagenic by generally accepted
criteria requiring both observations to
occur. The water soluble nickel salts at the
majority of the administered doses pro-
duced significant increases (p<0.05) in
mutation rate and raised cytosolic nickel
levels, but had relatively low nickel concen-
trations in the nuclear compartment.
[Relatively low nuclear concentrations of
nickel have also been observed by
T. Malinski (Oakland University, Roches-
ter, MI) when cells were exposed to nickel
salts (personal communication)]. A number
of interpretations of these observations
are possible.
From the PCR characterization, three
qualitative classes of mutations were
observed (Figure 5). Sequence analysis ofa
number of EMS mutants has shown that
point mutations are members of this first
family (both PCR gpt bands present). In
addition, small deletions of several base
pairs or frameshift mutations theoretically
would also be scored in this first class.
Deletions ofall or part ofthe gptlocus are
assigned to the second empirical type
(small band absent), while multilocus dele-
tions or damage are believed to correspond
to the third category of mutants (both
bands absent). Although it can be postu-
lated that small mutations (i.e., point,
frameshift, or deletion) in critical regions of
primer annealing may result in similar pro-
files, the corroboration ofmutation profiles
utilizing a second distinct set of PCR
primers argues against this conclusion.
(Note that in this discussion gene deletion
denotes an operational definition, i.e., the
inability ofa DNA segment to be amplified
by PCR, and does not necessarily imply the
total physical absence ofa gene.) The pro-
file of damage inflicted was found to
depend on the nature of the nickel com-
pound. Ni(OH)2 and NiSO4 induced sub-
stantial increases in deletions in all or part
of the gpt gene compared to EMS and
spontaneous mutants. Thus, although the
mutagenicity testing showed the nickel
compounds to be weakly mutagenic, they
were able to induce mutations with molec-
ular lesion profiles distinct from sponta-
neous changes. Perhaps, as in wild-type
CHO cells, cytotoxicity associated with the
clastogenic properties ofnickel compounds
Tgobff Pm wLa
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Figure 5. PCR analysis ofAS52 gptmutants: distribution
of PCR products determined by electrophoresis.
Designation of mutant types was based on an examina-
tion of PCR amplification products on standard 1%
agarose gels. Three types of gel patterns were observed
as indicated in the key shown above:
(a), both PCR bands present (point mutation, small dele-
tion, or frameshift) or (b), the smaller band not observed
(active gene absent) or(c), both PCR bands not observed
(active gene and pseudogene absent). Control mutants
denote those arising spontaneously in the absence ofany
testchemical.
Volume 102, Supplement3, September 1994 75FLETCHERETAL.
circumvents the observation of strongly
positive mutagenic responses inAS52 cells.
Interpretations
An examination of the nickel uptake and
cytotoxicity data suggests that, as a first
approximation, the "Nickel-Ion Hypothe-
sis" holds. While administered LC50 doses
differed by a factor of 75 for the 11 nickel
compounds studied, the corresponding
intracellular (cytosolic and nuclear), non-
particulate nickel concentrations varied
only by about a factor of 10. (The cytosolic
nickel levels for NiCO3 are excluded in this
analysis; below.) The observed cytosolic
nickel levels did not correlate with the LC50
values, while the nuclear concentrations did
(p<0.01) (Tables 2,A1).
By comparing the administered doses
with the measured nickel levels in the
cytosol and nucleus, one can see that the
Ni(OH)2, NiCO3, "amorphous NiS" and
Ni3S2 were the most efficient in delivering
nickel to cells (measured as nonparticulate
or "dissolved" form) and were also the most
toxic. This observation is consistent with
the Nickel-Ion Hypothesis. The fact that all
the nickel compounds produce mutagenic
responses (p<0.05) supports the notion of
the Nickel-Ion Hypothesis that all nickel
compounds are potentially genotoxic ifthey
release nickel(II) ions.
It is reasonable to suggest that the mea-
sured, nonparticulate (dissolved) cytosolic
nickel represents different compartments
for the uptake from salt solutions than for
the incorporation ofparticulate nickel com-
pounds. It is known that phagocytized par-
ticulates of Ni3S2 are often present in
cytoplasmic vacuoles (5,24). It is hypothe-
sized that within vacuoles particulates
undergo dissolution and that nickel(II) ions
can be released from them to the cytosol
(12,25). Presumably, the lysing step
employed in releasing cytosolic nickel in the
present study (see Figure 1) makes available
for measurement nickel(II) ions present in
both vacuoles and the cytosol proper. On
the other hand, nickel(II) ions taken up
from salt solutions [perhaps via calcium
channels, (26)] may be expected to occur
only in the cytosol proper, likely bound to
proteins and low-molecular-mass ligands.
In this case, only this pool is suspected of
being released in the cell-membrane lysing
step.
It is obvious from the present study that
factors other than intracellular nickel con-
centration contribute to the cytotoxicity.
Nickel compounds are known to exhibit
differential surface activities which, for
example, result in quite different abilities to
induce haemolysis in human
erythrocytes (27). Consequently, physico-
chemical surface or cell interactions proba-
bly contribute to cell injury. Such an effect
may be especially important when relatively
large doses are required, such as for the
green and Ni(III)/Li nickel oxides.
Nickel-induced mutagenicity also seems
to have a number ofdeterminants. This can
be seen by comparing the mutagenicity and
the cytosolic/nuclear nickel levels for the
particulate compounds with the water-solu-
ble nickel salts (Tables 3,Al). Con-
sequently, low nickel levels relative to those
found in the cytosol fraction are observed
in the nuclei of cells exposed to the chlo-
ride, sulfate, or acetate salts (and perhaps
also to the carbonate, which appears to be
the most soluble of the particulate com-
pounds). In contrast, the cytosolic concen-
trations are substantially elevated for these
compounds. A number ofimplications and
interpretations flowfrom this observation.
The simplest interpretation is that intra-
cellular compartmentalization of nickel
results in different mechanisms ofgenotoxi-
city. It is tempting to assign the mutagenic-
ity ofnickel salts to high levels ofnickel in
the cytoplasm, which, through indirect
effects damage the genome. One such indi-
rect mechanism might be related to the
demonstrated ability of certain nickel(II)
complexes of natural ligands to participate
in active oxygen biochemistry (12,28-31).
Such processes generate radical species that
are known to damage DNA. By contrast,
high concentrations ofnickel(II) ions in the
nucleus are capable, on binding to DNA
and nuclear proteins, of damaging DNA
[e.g., depurination, (26)], or inducing
changes in chromosomal conformation that
may result in permanent changes in gene
expression (12,29,32,33). These interpreta-
tions receive strong support from the work
of Sen and Costa (25), who demonstrated
that the pathway of delivery of nickel to
CHO cells determined the type of interac-
tion with chromosomes. Thus nickel(II)
salts, like crystalline NiS, induced chromo-
somal aberrations (gaps, breaks, and
exchanges), but only the particulate com-
pounds produced X-chromosome fragmen-
tation. However, when nickel(II) was
delivered to the cell in liposomes (as NiCl2
or the nickel(II) complex of bovine serum
albumin), X-chromosome fragmentation
was also observed. Our work corroborates
these observations by Sen and Costa (25).
The measured nonparticulate nickel con-
centrations support the notion that differ-
ential intracellular compartmentallzatlon of
nickel determines such differences in geno-
toxic responses.
The response to NiCO3 warrants addi-
tional comment. Crystallinity has generally
been accepted as a prerequisite for the
uptake ofnickel compounds by phagocyto-
sis. Although poorly crystalline by X-ray
diffraction analysis, the NiCO3 used in our
cytotoxicity and mutagenicity studies was
considerably more efficient than the water-
soluble salts in delivering nickel to the cells.
Of course, microcrystallinity cannot be
ruled out. Like the salts, the nuclear frac-
tion ofnickel in this case was also found to
be small compared to the cytosolic levels
observed, which is consistent with its solu-
bility. This suggests that the NiCO3
induced mutagenicity, at least in part, in a
fashion similar to the salts. Perhaps on
uptake, the degree ofvacuolation is less, or
the extent ofdissolution in vacuoles greater,
than for the other solids. Nonvacuolized
Ni3S2 has been reported in CHO cells
(5,24).
Conclusions
In conclusion, our work has demonstrated
that nonparticulate, intracellular nickel(II)
concentrations, irrespective of the parent
compound, constitute an important deter-
minant in the cytotoxicity and mutagenicity
responses byAS52 CHO cells to nickel com-
pounds. This finding is consistent with the
Nickel-Ion Hypothesis. However, this
hypothesis must be modified to allow for dif-
ferential compartmentalization of nonpartic-
ulate dissolved nickel within the cell that is
dependent on the nickel-uptake pathway, as
well as mechanical cell surface effects in case
of relatively nontoxic compounds. The
uptake of particulates by phagocytosis
appears to elevate the measured, nonparticu-
late nickel levels in both the cytosol and the
nucleus, while nickel from salts accumulates
preferentially in the cytosol. These results
suggest thatcytosolicand nudearnickel accu-
mulations (in nonparticulate form) appear to
produce mutations by different mechanisms.
The mutant profile analysis suggests that
induction ofmutations at levels only slighdy
above background may indeed be indicative
of the mutagenic potential of nickel com-
pounds. It appears that there are method-
ologic problems involved in testing "weak"
mutagens and that alternative approaches are
necessary in classifying the mutagenicity of
nickel and other compounds. The PCR
analysis reported illustrates the potential of
employing molecular biology techniques in a
complementary manner.
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APPENDIX
Table Al. Nickel content in the cytosol and nuclei of AS52 cells.a
Amount addedb Cytosol Nuclei Correaltion
pg/ml pg Ni/106cells pg Ni/i 06cells coefficient, (r)
Compound Compound Ni Avg Std Range Avg Std Range Cytosol Nuclei
Ni(OH)2 1.9 1.1 0.088 0.035 0.059 - 0.135 0.113 0.065 0.067 - 0.159 0.999c 0.891d
0.039 - 0.131
0.064 - 0.104
0.091 - 0.175
0.208 - 0.375
0.022 - 0.022
0.050 - 0.051
0.049 - 0.086
0.092 - 0.117
0.066 - 0.128
0.015 - 0.024
0.025 - 0.027
0.018 - 0.071
0.031 - 0.097
0.027 - 0.090
0.069 - 0.129
0.128 - 0.442
0.082 - 0.441
0.028 - 0.050
0.032 - 0.052
0.044 - 0.049
0.017 - 0.065
0.029 - 0.085
0.004 - 0.010
0.005 - 0.006
0.013 - 0.022
0.005 - 0.013
0.011 - 0.023
0.069 - 0.074
0.066 - 0.175
0.061 - 0.079
0.080 - 0.092
0.115- 0.150
0.021 - 0.033
0.039 - 0.041
0.032 - 0.111
0.046 - 0.051
0.057 - 0.139
0.067 - 0.085
0.095 - 0.159
0.111 - 0.178
0.002 - 0.005
0.005 - 0.008
0.005 - 0.005
0.009 - 0.016
0.014 - 0.018
0.003 - 0.009
0.006 - 0.007
0.006 - 0.017
0.008 - 0.008
0.009 - 0.013
0.005 - 0.006
0.006 - 0.010c
0.008 - 0.014
0.010 - 0.022
0.015 - 0.025
0.966c 0.916d
0.988c 0.882d
0.970c 0.858
0.973c 0.939d
0.943d 0.951d
0.983c 0.539
0.994c 0.336
0.985c 0.912d
0.970c 0.930d
0.935d 0.723
0.997c 0.991C
(continued)
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NiCO3
NiCO3
crystalline
NiO, black
NiO, green
3.1 1.7
4.3 2.4
6.2 3.4
9.9 5.5
6.4 2.5
11.2 4.4
16.0 6.2
21.1 8.2
28.8 11.2
2.5 1.0
5.0 1.9
7.5 2.9
10.0 3.8
15.0 5.7
20.0 7.6
30.0 11.4
40.0 15.2
12.2 9.5
18.0 14.0
23.3 18.1
28.5 22.2
40.9 31.8
109 85
183 143
229 180
358 281
0.136
0.202
0.274
0.421
0.260
0.536
0.854
1.014
1.161
0.077
0.146
0.204
0.246
0.444
0.444
0.764
0.640
0.076
0.098
0.094
0.129
0.181
0.029
0.035
0.062
0.094
0.043
0.059
0.079
0.105
0.198
0.163
0.281
0.371
0.011
0.022
0.006
0.007
0.042
0.045
0.148
0.146
0.299
0.038
0.034
0.020
0.038
0.054
0.012
0.009
0.029
0.071
0.099 - 0.181
0.149 - 0.280
0.191 - 0.355
0.361 - 0.578
0.091 - 0.478
0.402 - 0.718
0.554 - 1.112
0.585 - 1.230
1.153 - 1.170
0.061 - 0.093
0.142 - 0.150
0.198 - 0.209
0.217 - 0.276
0.412 - 0.475
0.340 - 0.549
0.661 - 0.867
0.428 - 0.852
0.044- 0.131
0.064 - 0.132
0.072 - 0.120
0.099 - 0.181
0.121 - 0.251
0.018 - 0.047
0.027 - 0.043
0.028 - 0.098
0.046 - 0.175
0.085
0.084
0.133
0.292
0.022
0.051
0.067
0.104
0.097
0.020
0.026
0.045
0.064
0.059
0.099
0.285
0.262
0.039
0.042
0.046
0.041
0.057
0.007
0.005
0.017
0.045
0.065
0.028
0.060
0.11
0.000
0.001
0.026
0.018
0.044
0.006
0.001
0.038
0.047
0.045
0.042
0.222
0.253
0.015
0.014
0.003
0.034
0.039
0.004
0.000
0.006
Li2Ni8l0O
NiS
amorphous
Ni7S6
Ni3S2
NiCI2
5 hr
NiSO4
5 hr
Ni(CH3COO)2
5 hr
52 38
83 60
104 76
139 100
201 145
4.4 1.8
6.9 2.8
9.5 3.9
12.7 5.2
17.4 7.1
4.7 3.2
8.3 5.7
12.7 8.6
15.5 10.5
28.4 19.3
2.1 1.6
4.1 3.0
5.9 4.3
8.5 6.2
12.4 9.1
1.0 59
2.0 117
3.0 176
4.0 235
5.0 293
1.0 59
2.0 117
3.0 176
4.0 235
5.0 293
1.0 59
2.0 117
3.0 176
4.0 235
5.0 293
0.024
0.060
0.061
0.062
0.116
0.108
0.145
0.267
0.290
0.420
0.043
0.068
0.082
0.099
0.189
0.076
0.141
0.195
0.235
0.421
0.079
0.182
0.250
0.269
0.324
0.077
0.155
0.260
0.267
0.288
0.090
0.158
0.253
0.312
0.374
0.014
0.028
0.022
0.010
0.049
0.044
0.089
0.091
0.106
0.136
0.016
0.024
0.015
0.008
0.001
0.023
0.044
0.032
0.159
0.194
0.014
0.064
0.115
0.101
0.099
0.025
0.080
0.119
0.103
0.061
0.022
0.083
0.104
0.158
0.147
0.015 - 0.040
0.040 - 0.080
0.037 - 0.080
0.055 - 0.069
0.082 - 0.151
0.056 - 0.162
0.075 - 0.263
0.182 - 0.346
0.178 - 0.428
0.260 - 0.569
0.026 - 0.061
0.046 - 0.099
0.072 - 0.093
0.093 - 0.105
0.188 - 0.189
0.058 - 0.108
0.104 - 0.200
0.165 - 0.234
0.093 - 0.406
0.216 - 0.638
0.060 - 0.091
0.123 - 0.270
0.127 - 0.404
0.169 - 0.400
0.211 - 0.438
0.060 - 0.114
0.093 - 0.272
0.169 - 0.435
0.186 - 0.407
0.235 - 0.374
0.068 - 0.110
0.064 - 0.266
0.154 - 0.399
0.138 - 0.515
0.182 - 0.495
0.009
0.010
0.017
0.027
0.031
0.072
0.121
0.070
0.086
0.133
0.027
0.040
0.072
0.045
0.016
0.048
0.098
0.076
0.127
0.145
0.003
0.006
0.005
0.013
0.016
0.006
0.007
0.012
0.008
0.011
0.005
0.008
0.011
0.016
0.020
0.006
0.009
0.003
0.077
0.012
0.008
0.025
0.009
0.001
0.056
0.004
0.059
0.013
0.045
0.047
0.002
0.002
0.001
0.005
0.003
0.004
0.001
0.008
0.000
0.003
0.001
0.003
0.004
0.009
0.007
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Table Al. (continued). Nickel content in the cytosol and nuclei ofAS52 cells.a
Amountaddedb Cytosol Nuclei Correaltion
pg/ml pg Ni/1 6cells pg Ni/i06cells coefficient, (r)
Compound Compound Ni Avg Std Range Avg Std Range Cytosol Nuclei
NiCI2 0.25 14.7 0.053 0.961c
24 hr 0.50 29.4 0.077
0.75 44.0 0.180
1.00 58.7 0.184
1.25 73.4 0.231
NiSO4 0.25 14.7 0.048
0.958d 0.50 29.4 0.095
24 hr 0.75 44.0 0.154
1.00 58.7 0.146
1.25 73.4 0.238
Ni(CH3COO)2 0.25 14.7 0.048
0.798 0.50 29.4 0.160
24hr 0.75 44.0 0.111
1.00 58.7 0.287
1.25 73.4 0.219
Negative 0 0.002 0.001 0.001 - 0.003 0.002 0.001 0.001 - 0.003
controls
(no addition)
'AS52 cells were seeded inF12/10% FBS medium at 0.5-1.0*106 cells per 100-mm diameter dish 1to 2 days before treatment. The cells were exposed to the range of nickel com-
pounds in serum-free medium at the concentrations indicated for 24 hr (or 5-hr exposure for nickel salts as noted). The cells were rinsed to remove extracellular nickel and then
trypsinized, pelleted, rinsed, and counted. Thecellswere lysed in hypotonic buffer+ NonidetP-40, and centrifuged to pelletthe nuclei and particulates. The supernatant(referredto as
the cytosol) was keptforanalysis. The pelletwas digested with DNAse followed by Proteinase K/SDS andthe particulates removed bycentrifugation. The supernatant consisting of
the nuclear nickel was analyzed for nickel content. Averages and standard deviations(std)were obtained based on four replicate experimentsforthe cytosolic nickel and two experi-
ments forthe nuclear nickel content.. bTest doses were selected to correspond to formal survival rates of 80%, 65%, 50%, 35%, and 20%. cSignificant at the .01 probability level
dSignificant atthe .05probability level.
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